Stockreport

Aspire Biopharma regains Nasdaq minimum bid price compliance [Seeking Alpha]

Aspire Biopharma Holdings, Inc.  (ASBP) 
PDF Aspire remains subject to an extension period to demonstrate compliance with Nasdaq's $2.5M stockholders' equity requirement. ASBP shares up 2% premarket. More on A [Read more]